Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol: a multicentre randomised controlled trial

Remimazolam, a short-acting benzodiazepine, may be used for induction and maintenance of total intravenous anaesthesia, but its role in the management of patients with multiple comorbidities remains unclear. In this phase 3 randomised controlled trial, we compared the anaesthetic efficacy and the in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Fechner, Jörg (VerfasserIn) , El-Boghdadly, K. (VerfasserIn) , Spahn, Donat Rudolf (VerfasserIn) , Motsch, Johann (VerfasserIn) , Struys, M.M.R.F. (VerfasserIn) , Duranteau, O. (VerfasserIn) , Ganter, M.T. (VerfasserIn) , Richter, T. (VerfasserIn) , Hollmann, M.W. (VerfasserIn) , Rossaint, Rolf (VerfasserIn) , Bercker, Sven (VerfasserIn) , Rex, Steffen (VerfasserIn) , Drexler, Berthold (VerfasserIn) , Schippers, Frank (VerfasserIn) , Morley, A. (VerfasserIn) , Ihmsen, Harald (VerfasserIn) , Kochs, E. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 14 January 2024
In: Anaesthesia
Year: 2024, Jahrgang: 79, Heft: 4, Pages: 410-422
ISSN:1365-2044
DOI:10.1111/anae.16205
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1111/anae.16205
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/anae.16205
Volltext
Verfasserangaben:J. Fechner, K. El-Boghdadly, D.R. Spahn, J. Motsch, M.M.R.F. Struys, O. Duranteau, M.T. Ganter, T. Richter, M.W. Hollmann, R. Rossaint, S. Bercker, S. Rex, B. Drexler, F. Schippers, A. Morley, H. Ihmsen, E. Kochs and on behalf of the Surgery Under Remimazolam-Total IntraVenous Anaesthesia (SURE-TIVA) Trial Group

MARC

LEADER 00000caa a2200000 c 4500
001 1884325459
003 DE-627
005 20240703160612.0
007 cr uuu---uuuuu
008 240326s2024 xx |||||o 00| ||eng c
024 7 |a 10.1111/anae.16205  |2 doi 
035 |a (DE-627)1884325459 
035 |a (DE-599)KXP1884325459 
035 |a (OCoLC)1443666777 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Fechner, Jörg  |e VerfasserIn  |0 (DE-588)133056880  |0 (DE-627)533310180  |0 (DE-576)299593665  |4 aut 
245 1 0 |a Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol  |b a multicentre randomised controlled trial  |c J. Fechner, K. El-Boghdadly, D.R. Spahn, J. Motsch, M.M.R.F. Struys, O. Duranteau, M.T. Ganter, T. Richter, M.W. Hollmann, R. Rossaint, S. Bercker, S. Rex, B. Drexler, F. Schippers, A. Morley, H. Ihmsen, E. Kochs and on behalf of the Surgery Under Remimazolam-Total IntraVenous Anaesthesia (SURE-TIVA) Trial Group 
264 1 |c 14 January 2024 
300 |b Illustrationen 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 26.03.2024 
520 |a Remimazolam, a short-acting benzodiazepine, may be used for induction and maintenance of total intravenous anaesthesia, but its role in the management of patients with multiple comorbidities remains unclear. In this phase 3 randomised controlled trial, we compared the anaesthetic efficacy and the incidence of postinduction hypotension during total intravenous anaesthesia with remimazolam vs. propofol. A total of 365 patients (ASA physical status 3 or 4) scheduled for elective surgery were assigned randomly to receive total intravenous anaesthesia with remimazolam (n = 270) or propofol (n = 95). Primary outcome was anaesthetic effect, quantified as the percentage of time with Narcotrend® Index values ≤ 60, during surgery (skin incision to last skin suture), with a non-inferiority margin of -10%. Secondary outcome was the incidence of postinduction hypotensive events. Mean (SD) percentage of time with Narcotrend Index values ≤ 60 during surgery across all patients receiving remimazolam (93% (20.7)) was non-inferior to propofol (99% (4.2)), mean difference (97.5%CI) -6.28% (-8.89-infinite); p = 0.003. Mean (SD) number of postinduction hypotension events was 62 (38.1) and 71 (41.1) for patients allocated to the remimazolam and propofol groups, respectively; p = 0.015. Noradrenaline administration events (requirement for a bolus and/or infusion) were also lower in patients allocated to remimazolam compared with propofol (14 (13.5) vs. 20 (14.6), respectively; p < 0.001). In conclusion, in patients who were ASA physical status 3 or 4, the anaesthetic effect of remimazolam was non-inferior to propofol. 
650 4 |a hypotension 
650 4 |a propofol 
650 4 |a remimazolam 
650 4 |a total intravenous anaesthesia 
700 1 |a El-Boghdadly, K.  |e VerfasserIn  |4 aut 
700 1 |a Spahn, Donat Rudolf  |d 1957-  |e VerfasserIn  |0 (DE-588)1079392238  |0 (DE-627)840954964  |0 (DE-576)452438489  |4 aut 
700 1 |a Motsch, Johann  |d 1952-  |e VerfasserIn  |0 (DE-588)1059446626  |0 (DE-627)798468319  |0 (DE-576)415532876  |4 aut 
700 1 |a Struys, M.M.R.F.  |e VerfasserIn  |4 aut 
700 1 |a Duranteau, O.  |e VerfasserIn  |4 aut 
700 1 |a Ganter, M.T.  |e VerfasserIn  |4 aut 
700 1 |a Richter, T.  |e VerfasserIn  |4 aut 
700 1 |a Hollmann, M.W.  |e VerfasserIn  |4 aut 
700 1 |a Rossaint, Rolf  |d 1958-  |e VerfasserIn  |0 (DE-588)1018930213  |0 (DE-627)683445863  |0 (DE-576)169616371  |4 aut 
700 1 |a Bercker, Sven  |d 1970-  |e VerfasserIn  |0 (DE-588)123114756  |0 (DE-627)082356025  |0 (DE-576)293562377  |4 aut 
700 1 |a Rex, Steffen  |d 1971-  |e VerfasserIn  |0 (DE-588)120813416  |0 (DE-627)080902634  |0 (DE-576)292397976  |4 aut 
700 1 |a Drexler, Berthold  |d 1971-  |e VerfasserIn  |0 (DE-588)122943732  |0 (DE-627)706100557  |0 (DE-576)293487278  |4 aut 
700 1 |a Schippers, Frank  |d 1970-  |e VerfasserIn  |0 (DE-588)129672017  |0 (DE-627)477113435  |0 (DE-576)297778633  |4 aut 
700 1 |a Morley, A.  |e VerfasserIn  |4 aut 
700 1 |a Ihmsen, Harald  |d 1962-  |e VerfasserIn  |0 (DE-588)122973690  |0 (DE-627)706113322  |0 (DE-576)293502471  |4 aut 
700 1 |a Kochs, E.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Anaesthesia  |d Oxford [u.a.] : Wiley-Blackwell, 1946  |g 79(2024), 4, Seite 410-422  |h Online-Ressource  |w (DE-627)32042779X  |w (DE-600)2003379-5  |w (DE-576)090954645  |x 1365-2044  |7 nnas  |a Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol a multicentre randomised controlled trial 
773 1 8 |g volume:79  |g year:2024  |g number:4  |g pages:410-422  |g extent:13  |a Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol a multicentre randomised controlled trial 
856 4 0 |u https://doi.org/10.1111/anae.16205  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/anae.16205  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20240326 
993 |a Article 
994 |a 2024 
998 |g 1059446626  |a Motsch, Johann  |m 1059446626:Motsch, Johann  |d 910000  |d 910300  |d 50000  |e 910000PM1059446626  |e 910300PM1059446626  |e 50000PM1059446626  |k 0/910000/  |k 1/910000/910300/  |k 0/50000/  |p 4 
999 |a KXP-PPN1884325459  |e 4503891189 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"13 S.","noteIll":"Illustrationen"}],"person":[{"display":"Fechner, Jörg","role":"aut","family":"Fechner","given":"Jörg","roleDisplay":"VerfasserIn"},{"family":"El-Boghdadly","given":"K.","roleDisplay":"VerfasserIn","display":"El-Boghdadly, K.","role":"aut"},{"given":"Donat Rudolf","family":"Spahn","roleDisplay":"VerfasserIn","display":"Spahn, Donat Rudolf","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Motsch","given":"Johann","role":"aut","display":"Motsch, Johann"},{"roleDisplay":"VerfasserIn","family":"Struys","given":"M.M.R.F.","role":"aut","display":"Struys, M.M.R.F."},{"family":"Duranteau","given":"O.","roleDisplay":"VerfasserIn","display":"Duranteau, O.","role":"aut"},{"family":"Ganter","given":"M.T.","roleDisplay":"VerfasserIn","display":"Ganter, M.T.","role":"aut"},{"given":"T.","family":"Richter","roleDisplay":"VerfasserIn","display":"Richter, T.","role":"aut"},{"roleDisplay":"VerfasserIn","given":"M.W.","family":"Hollmann","role":"aut","display":"Hollmann, M.W."},{"family":"Rossaint","given":"Rolf","roleDisplay":"VerfasserIn","display":"Rossaint, Rolf","role":"aut"},{"family":"Bercker","given":"Sven","roleDisplay":"VerfasserIn","display":"Bercker, Sven","role":"aut"},{"role":"aut","display":"Rex, Steffen","roleDisplay":"VerfasserIn","family":"Rex","given":"Steffen"},{"family":"Drexler","given":"Berthold","roleDisplay":"VerfasserIn","display":"Drexler, Berthold","role":"aut"},{"display":"Schippers, Frank","role":"aut","given":"Frank","family":"Schippers","roleDisplay":"VerfasserIn"},{"display":"Morley, A.","role":"aut","given":"A.","family":"Morley","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Ihmsen","given":"Harald","role":"aut","display":"Ihmsen, Harald"},{"family":"Kochs","given":"E.","roleDisplay":"VerfasserIn","display":"Kochs, E.","role":"aut"}],"title":[{"title":"Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol","title_sort":"Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol","subtitle":"a multicentre randomised controlled trial"}],"origin":[{"dateIssuedDisp":"14 January 2024","dateIssuedKey":"2024"}],"language":["eng"],"recId":"1884325459","relHost":[{"note":["Gesehen am 12.02.2021"],"part":{"issue":"4","extent":"13","volume":"79","year":"2024","text":"79(2024), 4, Seite 410-422","pages":"410-422"},"id":{"doi":["10.1111/(ISSN)1365-2044"],"issn":["1365-2044"],"eki":["32042779X"],"zdb":["2003379-5"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"32042779X","origin":[{"publisher":"Wiley-Blackwell ; Blackwell Science","publisherPlace":"Oxford [u.a.] ; Oxford [u.a.]","dateIssuedKey":"1946","dateIssuedDisp":"1946-"}],"language":["eng"],"disp":"Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol a multicentre randomised controlled trialAnaesthesia","title":[{"title_sort":"Anaesthesia","title":"Anaesthesia","subtitle":"the official journal of the Association of Anaesthesists of Great Britain and Ireland"}],"pubHistory":["1.1946 -"],"physDesc":[{"extent":"Online-Ressource"}]}],"id":{"doi":["10.1111/anae.16205"],"eki":["1884325459"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 26.03.2024"],"name":{"displayForm":["J. Fechner, K. El-Boghdadly, D.R. Spahn, J. Motsch, M.M.R.F. Struys, O. Duranteau, M.T. Ganter, T. Richter, M.W. Hollmann, R. Rossaint, S. Bercker, S. Rex, B. Drexler, F. Schippers, A. Morley, H. Ihmsen, E. Kochs and on behalf of the Surgery Under Remimazolam-Total IntraVenous Anaesthesia (SURE-TIVA) Trial Group"]}} 
SRT |a FECHNERJOEANAESTHETI1420